Prokinetic drugs Market 2027 Type, Application and Geography | The Insight Partners

Prokinetic drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Metoclopramide, Domperidone, Cisapride, Others); Application (Gastroparesis, Constipation, Reflux Esophagitis, Functional Dyspepsia) and Geography

Report Code: TIPRE00014477 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Prokinetic agent (also promotility agent, gastroprokinetic agent, or gastrokinetic agent) are drugs that enhance the stomach/gut's emptying and enhance the gut's contractions/co-ordination. They are used to treat specific gastrointestinal symptoms, including constipation, heartburn, abdominal discomfort, bloating, nausea and vomiting, and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.

MARKET DYNAMICS

Factors like increased clinical approval by regulatory bodies for global drug consumption and rise in adult and pediatric motility disorders will propel the prokinetic drugs market's growth. However, risk factors associated with the consumption of drugs like serious cardiac events can hamper the market growth.

MARKET SCOPE

The "Prokinetic Drugs Market Analysis to 2027" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of prokinetic drugs market with detailed market segmentation with type and application. The prokinetic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in prokinetic drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Prokinetic drugs market is segmented on the basis of type and application. On the basis of type, the prokinetic drugs market is divided into metoclopramide, domperidone, cisapride and others. On basis of application, market can be segmented into gastroparesis, constipation, reflux esophagitis and functional dyspepsia.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the prokinetic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prokinetic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

`The report analyzes factors affecting prokinetic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the prokinetic drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in bacteria filters market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from prokinetic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for prokinetic drugs in the global market. Below mentioned is the list of few companies engaged in the prokinetic drugs market.

The report also includes the profiles of key players in prokinetic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Johnson and Johnson
  •  Sanofi S.A.
  •  Cadila Pharmaceuticals.
  •  Hanmi Pharm Co., Ltd.
  •  Kyowa Kirin Co., Ltd.
  •  Pfizer Inc.
  •  Teva Pharmaceutical Industries Ltd.
  •  Medley Pharmaceuticals Ltd
  •  Sumitomo Dainippon Pharma Co., Ltd. (Sumitomo Chemical)
  •  Tranzyme Pharma, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS


1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prokinetic Drugs Market - By Type
1.3.2 Prokinetic Drugs Market - By Application
1.3.3 Prokinetic Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROKINETIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PROKINETIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROKINETIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROKINETIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. PROKINETIC DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PROKINETIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. METOCLOPRAMIDE
7.3.1. Overview
7.3.2. Metoclopramide Market Forecast and Analysis
7.4. DOMPERIDONE
7.4.1. Overview
7.4.2. Domperidone Market Forecast and Analysis
7.5. CISAPRIDE
7.5.1. Overview
7.5.2. Cisapride Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PROKINETIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTROPARESIS
8.3.1. Overview
8.3.2. Gastroparesis Market Forecast and Analysis
8.4. CONSTIPATION
8.4.1. Overview
8.4.2. Constipation Market Forecast and Analysis
8.5. REFLUX ESOPHAGITIS
8.5.1. Overview
8.5.2. Reflux Esophagitis Market Forecast and Analysis
8.6. FUNCTIONAL DYSPEPSIA
8.6.1. Overview
8.6.2. Functional Dyspepsia Market Forecast and Analysis

9. PROKINETIC DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prokinetic Drugs Market Overview
9.1.2 North America Prokinetic Drugs Market Forecasts and Analysis
9.1.3 North America Prokinetic Drugs Market Forecasts and Analysis - By Type
9.1.4 North America Prokinetic Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prokinetic Drugs Market
9.1.5.1.1 United States Prokinetic Drugs Market by Type
9.1.5.1.2 United States Prokinetic Drugs Market by Application
9.1.5.2 Canada Prokinetic Drugs Market
9.1.5.2.1 Canada Prokinetic Drugs Market by Type
9.1.5.2.2 Canada Prokinetic Drugs Market by Application
9.1.5.3 Mexico Prokinetic Drugs Market
9.1.5.3.1 Mexico Prokinetic Drugs Market by Type
9.1.5.3.2 Mexico Prokinetic Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Prokinetic Drugs Market Overview
9.2.2 Europe Prokinetic Drugs Market Forecasts and Analysis
9.2.3 Europe Prokinetic Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe Prokinetic Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prokinetic Drugs Market
9.2.5.1.1 Germany Prokinetic Drugs Market by Type
9.2.5.1.2 Germany Prokinetic Drugs Market by Application
9.2.5.2 France Prokinetic Drugs Market
9.2.5.2.1 France Prokinetic Drugs Market by Type
9.2.5.2.2 France Prokinetic Drugs Market by Application
9.2.5.3 Italy Prokinetic Drugs Market
9.2.5.3.1 Italy Prokinetic Drugs Market by Type
9.2.5.3.2 Italy Prokinetic Drugs Market by Application
9.2.5.4 Spain Prokinetic Drugs Market
9.2.5.4.1 Spain Prokinetic Drugs Market by Type
9.2.5.4.2 Spain Prokinetic Drugs Market by Application
9.2.5.5 United Kingdom Prokinetic Drugs Market
9.2.5.5.1 United Kingdom Prokinetic Drugs Market by Type
9.2.5.5.2 United Kingdom Prokinetic Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prokinetic Drugs Market Overview
9.3.2 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prokinetic Drugs Market
9.3.5.1.1 Australia Prokinetic Drugs Market by Type
9.3.5.1.2 Australia Prokinetic Drugs Market by Application
9.3.5.2 China Prokinetic Drugs Market
9.3.5.2.1 China Prokinetic Drugs Market by Type
9.3.5.2.2 China Prokinetic Drugs Market by Application
9.3.5.3 India Prokinetic Drugs Market
9.3.5.3.1 India Prokinetic Drugs Market by Type
9.3.5.3.2 India Prokinetic Drugs Market by Application
9.3.5.4 Japan Prokinetic Drugs Market
9.3.5.4.1 Japan Prokinetic Drugs Market by Type
9.3.5.4.2 Japan Prokinetic Drugs Market by Application
9.3.5.5 South Korea Prokinetic Drugs Market
9.3.5.5.1 South Korea Prokinetic Drugs Market by Type
9.3.5.5.2 South Korea Prokinetic Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prokinetic Drugs Market Overview
9.4.2 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prokinetic Drugs Market
9.4.5.1.1 South Africa Prokinetic Drugs Market by Type
9.4.5.1.2 South Africa Prokinetic Drugs Market by Application
9.4.5.2 Saudi Arabia Prokinetic Drugs Market
9.4.5.2.1 Saudi Arabia Prokinetic Drugs Market by Type
9.4.5.2.2 Saudi Arabia Prokinetic Drugs Market by Application
9.4.5.3 U.A.E Prokinetic Drugs Market
9.4.5.3.1 U.A.E Prokinetic Drugs Market by Type
9.4.5.3.2 U.A.E Prokinetic Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prokinetic Drugs Market Overview
9.5.2 South and Central America Prokinetic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Prokinetic Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America Prokinetic Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Prokinetic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prokinetic Drugs Market
9.5.5.1.1 Brazil Prokinetic Drugs Market by Type
9.5.5.1.2 Brazil Prokinetic Drugs Market by Application
9.5.5.2 Argentina Prokinetic Drugs Market
9.5.5.2.1 Argentina Prokinetic Drugs Market by Type
9.5.5.2.2 Argentina Prokinetic Drugs Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PROKINETIC DRUGS MARKET, KEY COMPANY PROFILES
11.1. JOHNSON AND JOHNSON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANOFI S.A.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CADILA PHARMACEUTICALS.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HANMI PHARM.CO.,LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. KYOWA KIRIN CO., LTD.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MEDLEY PHARMACEUTICALS LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUMITOMO DAINIPPON PHARMA CO., LTD.(SUMITOMO CHEMICAL)
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TRANZYME PHARMA, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Johnson and Johnson
2. Sanofi S.A.
3. Cadila Pharmaceuticals.
4. Hanmi Pharm.Co.,Ltd.
5. Kyowa Kirin Co., Ltd.
6. Pfizer Inc.
7. Teva Pharmaceutical Industries Ltd.
8. Medley Pharmaceuticals Ltd
9. Sumitomo Dainippon Pharma Co., Ltd.(Sumitomo Chemical)
10. Tranzyme Pharma, Inc.
TIPRE00014477
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking